Volume 61, Number 4, August2016

  Editorial
309
Lawrence D. Devoe, M.D.
 
 
 


  Original Articles
311
Laura Garrison, M.A., Lawrence Leeman, M.D., M.P.H., Renate D. Savich, M.D., Hilda Gutierrez, B.S., William F. Rayburn, M.D., M.B.A., and Ludmila N. Bakhireva, M.D., Ph.D., M.P.H.
Polysubstance use was associated with higher risk of microcephaly (OR=4.7, 95% CI 2.0�10.8) and small-for-gestational-age status for weight (OR=3.7, 95% CI 1.4�9.4).
 
 


320
Cherie C. Hill, M.D., Evelyn L. Lockhart, M.D., Elizabeth Thames, R.N., Michael J. Paglia, M.D., Maria J. Small, M.D., M.P.H., Andra H. James, M.D., M.P.H., and Chad A. Grotegut, M.D., M.H.S.
The prevalence of severe postpartum hemorrhage did not change significantly over a 9-year period, but in later years there was greater utilization of misoprostol and platelet transfusion.
 
 


327
Vaishali Bhalani, M.D., Andrew Chang, M.D., Christen Adkins, M.D., Serena H. Chen, M.D., and Michael Scheiber, M.D., M.P.H.
Eradication of intrauterine lesions by hysteroscopic morcellation in subfertile women undergoing fertility therapy is safe and significantly increases subsequent pregnancy and live birth rates.
 
 


336
Mario Vega, M.D., Andrzej Breborowicz, M.D., Ph.D., Maytal Sauerbrun, M.D., Daniel Stein, M.D., Peter McGovern, M.D., and Martin Keltz, M.D.
Blastomere biopsy lowers blastulation rate but allows more euploid embryos to be available for transfer. The fully expanded or hatching blastulation rate appears unaffected.
 
 


341
Madeleine C. Macdonald, M.D., Barry W. Hancock, M.D., Matthew C. Winter, M.D., Robert E. Coleman, M.D., and John A. Tidy, M.D.
In patients with low-risk gestational trophoblastic neoplasia the overall complete response rate to 8-day methotrexate was 56%, with no significant difference between Stage I and III.
 
 


347
Kay Roussos-Ross, M.D., Samantha Winterrowd, M.D., and Kathryn Davidson, M.D.
Educating health care providers that postpartum sterilization should be considered an urgent medical procedure can increase the rates of completed sterilization procedures.
 
 


351
Mandy Man Yee Chu, M.B.B.S. (MRCOG), Ka Yu Tse, M.B.B.S. (MRCOG), Karen Kar Loen Chan, M.B.B.Chir. (FRCOG), Annie Nga Yin Cheung, M.B.B.S., M.D., Ph.D. (FRCPath), and Hextan Yuen Sheung Ngan, M.B.B.S., M.D. (FRCOG)
The prognosis of patients with placental site trophoblastic tumor is excellent if the disease is confined to the uterus, and adjuvant treatment after hysterectomy is not needed.
 
 


357
Vani C. Movva, M.B.B.S., Diedre Fleener, R.N., B.S.N., and Asha Rijhsinghani, M.D.
The role of feticide is limited in preventing unintended live births in second trimester pregnancy termination.
 
 


361
Ilknur Demir Karakilic, M.D., Onur Karabacak, M.D., Nese Karabacak, M.D., Ismail Guler, M.D., and Umit Korucuoglu, M.D.
Heavy menstrual bleeders with endometrial hyperplasia could be treated effectively with combined use of GnRH analogs and progestins for rapid cycle control and histological reversal.
 
 


368
Yu Xiao, Ph.D., Spiros Liatsikos, M.B., Ph.D., Ayesha Purohit, M.B., Dongmei Song, M.Med., and TinChiu Li, M.D., Ph.D.
Anti-M�llerian hormone and follicle-stimulating hormone measurements have no significant prognostic value on the outcome of pregnancy in women with recurrent miscarriage.
 
 


373
Momo Kan, M.D., Eiko Yamamoto, M.D., Ph.D., Kaoru Niimi, M.D., Ph.D., Koji Tamakoshi, M.D., Ph.D., Yoko Sekiya, M.D., Kimihiro Nishino, M.D., Kazuhiko Ino, M.D., Ph.D., and Fumitaka Kikkawa, M.D., Ph.D.
Routine second curettage for hydatidiform mole may not reduce gestational trophoblastic neoplasia or affect subsequent pregnancies.
 
 


380
Robert Hudecek, M.D., Ph.D., Martin Huser, M.D., Ph.D., Son a P�nkov�, M.D., Lenka Mekinov�, M.D., Jana Kadlecov�, M.D., and Pavel Ventruba, M.D., MBA
Laparoscopic myomectomy with epinephrine is effective and safe, resulting in a lower blood loss, shortened duration of surgery and hospitalization, and no appreciable complications.
 
 


385
Li Li, R.N., M.S.N., Dan Zeng, R.N., B.S.N., Fei Li, M.D., Ph.D., Dan Cui, Ph.D., and Yuanzhen Zhang, R.D.
History of ejaculation failure and anxiety are associated with an increased risk for ejaculation failure on the day of operation for assisted reproduction procedure.
 
 


  Case Reports
390
Miriam S. Krause, M.D., Henry Bohler, Jr., M.D., Greg L. Christensen, Ph.D., and Steven T. Nakajima, M.D.
Oocyte cryopreservation is a feasible option for couples opposed to embryo cryopreservation.
 
 


393
Charalampos Chatzicharalampous, M.D., and Mary A. Bray, M.D.
Acquired hematotrachelos is a rare condition and the diagnosis often poses a challenge, especially if there is no obvious history of cervical surgery or manipulation.
 
 


398
Tha�s Baert, M.D., Joris Vermeesch, Ph.D., Dirk Timmerman, M.D., Ph.D., Ignace Vergote, M.D., Ph.D., and Philippe Moerman, M.D., Ph.D.
The authors report a choriocarcinoma in situ diagnosed in a partial hydatidiform mole. This is the first reported case of a choriocarcinoma arising in a first trimester partial mole.